The company has announced that following a rigorous third-party analysis undertaken by ConsumerLab.com, both of its grades, Pure Krill oil (4014F) and High-Potency Krill oil (4225F), have been found to meet their specifications for Omega-3 and ConsumerLab.com’s strict quality criteria.
"Enzymotec carries two distinctive grades—one of which we believe to be 'best in class' Pure Krill Oil and the second is a proprietary high-potency grade," says Elzaphan Hotam, CEO of Enzymotec USA, Inc. "We are very pleased with these results obtained via an un-biased third party. This is of significant relevance because we are the only company who has been willing to test the quality of its krill oils by such a credible and well respected third party group as ConsumerLab.com."
ConsumerLab.com tested the products for their claimed amounts of Omega-3 fatty acids and freshness. They were also evaluated for their levels of the contaminants lead, mercury and PCBs. Products were held to the stringent criteria of the GOED Monograph for mercury and TOTOX value; CA Proposition 65 for lead; and the proposed EU criteria for dioxin-like PCBs.
ConsumerLab.com is a provider of independent test results and information that helps consumers and healthcare professionals evaluate health, wellness and nutrition products. It publishes results of its tests on its popular website, www.consumerlab.com. Since its founding in 1999, ConsumerLab.com has tested more than 2,800 products, representing over 350 different brands and nearly every type of popular supplement.
Enzymotec is an Israeli biotech company, which operates in the Pharmaceuticals, Infant nutrition and Nutraceutical segments. In the Dietary supplement sector, Enzymotec is a supplier of high-end active ingredients to major retailers across the world. The company’s main mission is to provide branded companies with a better value proposition in three main health areas: CVD management, improving cognitive performance and balanced nutrition for babies & toddlers. Enzymotec strategically researches and identifies concepts which have already gained market and scientific acceptance, such as: Omega-3, PS or plant-sterols and enhance their efficacy by mode of extraction, conjugation or modification. In order to increase value proposition of these concepts Enzymotec invests significant resources in supplying powerful marketing tools, clinical trials, regulatory affairs and patent protection while ensuring highest quality standards.